Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/38186

Trimethylolpropane triacrylate: Target Organs and Levels of Evidence for TR-576

Toxicology and Carcinogenesis Studies of Trimethylolpropane triacrylate (CASRN 15625-89-5) in F344/N Rats (Topical Application Studies)

Chemical (Study Title)
CASRN
Peer Review DateRoute/Exposure LevelsStudy Laboratory
Trimethylolpropane triacrylate
15625-89-5
02/08/2012Topical Application
R&M: 0, 0.3, 1.0, OR 3.0 MG/KG; 65/SEX/SPECIES/DOSE
Southern Research Institute

Levels of Evidence

Male Rats: Equivocal Evidence
TypeOrgan/Tissue (Lesion)
May Have Been Related
  • Malignant Mesothelioma: 0/50, 2/50, 2/50, 5/50
Non-Neoplastic Lesions
  • Skin (site of application): epidermis, hyperplasia; hyperkeratosis
Female Rats: No Evidence
TypeOrgan/Tissue (Lesion)
Non-Neoplastic Lesions
  • Skin (site of application): epidermis, hyperplasia; hyperkeratosis
Male Mice: No Evidence
TypeOrgan/Tissue (Lesion)
Non-Neoplastic Lesions
  • Skin (site of application): epidermis, hyperplasia; hyperplasia, melanocyte; inflammation, chronic
Female Mice: Some Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Liver: hepatoblastoma 0/50, 4/50, 0/50, 3/50; hepatocholangiocarcinoma 0/50, 0/50, 1/50, 2/50
  • Uterus: stromal polyp or stromal sarcoma 0/50, 1/50, 2/50, 6/50
Non-Neoplastic Lesions
  • Skin (site of application): epidermis, hyperplasia; hyperplasia, melanocyte; inflammation, chronic